News Archive

The state of Maryland and the Anne Arundel County Economic Development Corp. (AAEDC) announced today their support of Paragon Bioservices’ new commercial manufacturing facility under development in Anne Arundel County and the addition of 200 new jobs over the next four years. Earlier this year, Paragon, a leading biologics contract development and manufacturing organization (CDMO) with expertise in gene therapy and next-generation vaccines, announced plans to lease 150,000 square feet in the BW Gateway development on Harmans Road.

Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, announce a commercial agreement that enables Righton to sell Akonni’s products for nucleic acid purification and molecular diagnostics to researchers, clinical laboratories, and hospitals in China. The products to be sold include TruTip®, Akonni’s best-in-class sample preparation technology, which is low-cost and simple, yet highly effective at purifying DNA and RNA from the most difficult sample types. In addition, for diagnostic applications, Righton plans to commercialize Akonni’s TruDiagnosis® system based on the proprietary TruArray® multiplexed diagnostic solutions. Righton has made an equity investment of $7.5 million USD in Akonni’s series D fundraising round bringing the total investments in the Series D round to $13.9 million USD.

The Montgomery County Council on Tuesday unanimously approved Tuesday a county matching fund for businesses that receive federal grants.

Councilmember George Leventhal spearheaded the grant, which was co-sponsored by the eight remaining council members.

WellDoc®, a leading digital therapeutic company, announces today the formation of its scientific advisory team whose expertise spans cardiology, health behavior, endocrinology, primary care and pharmacy-based diabetes education and care. Richard Katz, MD, Janet Duni, RN, BSN, MPA, CCM, Pablo Mora, MD, Nancy D’Hondt, RPh, CDE, FAADE, Edwin Fisher, PhD and Charlene Quinn, PhD have each been involved in WellDoc’s digital health journey with product enhancement, evaluation, or implementation and have been asked to now formally serve as scientific advisors to the company.

Pharma major Lupin announced the launch of its Carbidopa Tablets 25mg having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Carbidopa Tablets, 25mg is the generic equivalent of Aton Pharma, Inc.’s Lodosyn® Tablets, 25 mg. It is indicated for use with carbidopa-levodopa or with levodopa in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism, which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication.

USC researchers have launched a massive scientific effort to construct a detailed, virtual 3-D model of the pancreatic beta cell and its components — a global project that aims to one day curb the worldwide rise of diabetes.

Eighteen companies ranging in maturity and focus, from software building to bag making, will be housed in the newly renovated HQ by the end of the month.

A pair of bio-oriented spaces in Baltimore are looking to provide extra help to scientists building companies out of discoveries.

The Inner Harbor–based Institute of Marine and Environmental Technology (IMET) and Baltimore Under Ground Science Space (BUGSS) have a new partnership, according to leaders from both spots.

TEDCO announced investments from its seed fund in five startups this week, including three from Baltimore.

Taken together, the latest funding from Maryland’s quasi-public agency backing early-stage companies totals $1.2 million. Here’s the funding breakdown: